Literature DB >> 8090883

Radiologic appearance of the irradiated larynx. Part II. Primary site response.

S K Mukherji1, A A Mancuso, I M Kotzur, W M Mendenhall, P S Kubilis, R P Tart, D Freeman, W R Lee.   

Abstract

PURPOSE: To evaluate the computed tomographic (CT) appearance of laryngeal tumors treated with radiation therapy and the ability of CT to depict persistent or residual tumor.
MATERIALS AND METHODS: Sixty-one patients with primary squamous cell carcinoma of the larynx or hypopharynx were treated with definitive radiation therapy. CT was performed in all patients before and after treatment.
RESULTS: In 32 of 41 patients with cancer controlled at the primary site, CT showed complete resolution of tumor, whereas in 10 of 14 patients in whom radiation therapy failed, there was minimal or no reduction in tumor. In a subpopulation of patients who underwent repeat imaging, 18 of 19 with tumor controlled at the primary site had complete resolution of tumor. Overall, in four of 13 patients with 50%-75% reduction in tumor size or persistent substantial asymmetry at CT, therapy eventually failed at the primary site.
CONCLUSION: Lesions that are reduced by 50% or less at 4-month follow-up CT are highly suspicious for treatment failure. Repeat CT studies every 4 months is recommended in addition to careful clinical follow-up.

Entities:  

Mesh:

Year:  1994        PMID: 8090883     DOI: 10.1148/radiology.193.1.8090883

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

1.  Normal laryngeal CT findings after supracricoid partial laryngectomy.

Authors:  N Bely-Toueg; P Halimi; O Laccourreye; F Laskri; D Brasnu; G Frija
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  Evaluation of head and neck squamous cell carcinoma after treatment.

Authors:  Suresh K Mukherji; Gregory T Wolf
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

3.  Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement.

Authors:  Jolijn Brouwer; Evelien J Bodar; Remco De Bree; Johannes A Langendijk; Jonas A Castelijns; Otto S Hoekstra; C René Leemans
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-11-19       Impact factor: 2.503

Review 4.  [Oropharyngeal pathologies].

Authors:  M Lell; F Hinkmann; F Gottwald; W Bautz; T Radkow
Journal:  Radiologe       Date:  2009-01       Impact factor: 0.635

5.  Evaluation of CT Changes in the Head and Neck After Cancer Treatment: Development of a Measurement Tool.

Authors:  Joseph M Aulino; Elizabeth M Wulff-Burchfield; Mary S Dietrich; Sheila H Ridner; Kenneth J Niermann; Jie Deng; Bethany A Rhoten; Jennifer K Doersam; Lee Ann Jarrett; Kyle Mannion; Barbara A Murphy
Journal:  Lymphat Res Biol       Date:  2018-02       Impact factor: 2.589

Review 6.  Current concepts of surveillance and its significance in head and neck cancer.

Authors:  Kapila Manikantan; Raghav C Dwivedi; Suhail I Sayed; K A Pathak; Rehan Kazi
Journal:  Ann R Coll Surg Engl       Date:  2011-11       Impact factor: 1.891

7.  Multiplanar functional imaging of the larynx and hypopharynx with multislice spiral CT.

Authors:  Michael M Lell; Holger Greess; Torsten Hothorn; Rolf Janka; Werner A Bautz; Ulrich Baum
Journal:  Eur Radiol       Date:  2004-10-08       Impact factor: 5.315

Review 8.  [Pretherapeutic and posttherapeutic laryngeal imaging].

Authors:  M Becker; K Burkhardt; A S Allal; P Dulguerov; O Ratib; C D Becker
Journal:  Radiologe       Date:  2009-01       Impact factor: 0.635

9.  Limited utility of routine surveillance MRI following chemoradiation for advanced-stage oropharynx carcinoma.

Authors:  Gerald T Kangelaris; Sue S Yom; Kim Huang; Steven J Wang
Journal:  Int J Otolaryngol       Date:  2010-08-31

Review 10.  Clinical applications of tumor volume measurements for predicting outcome in patients with squamous cell carcinoma of the upper aerodigestive tract.

Authors:  Suresh K Mukherji; Ilona M Schmalfuss; Jonas Castelijns; Anthony A Mancuso
Journal:  AJNR Am J Neuroradiol       Date:  2004-09       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.